MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Deposition of phosphorylated TDP-43 around the tip of deep brain stimulation leads

    G. Beck, R. Yamashita, Y. Yonenobu, K. Maeda, S. Murayama, H. Mochizuki (Suita city, Japan)

    Objective: The objective of this study is to investigate the depositions of abnormal proteins, including phosphorylated tau (p-tau) and phosphorylated transactivation response DNA-binding protein of…
  • 2024 International Congress

    Evaluation of the results of neuromodulation of the Subthalamic Nucleus (STN) in patients with Parkinson’s Disease (PD) depending on the anesthesia used during stereotactic electrode implantation.

    V. Bayarchyk, A. Buniak (Minsk, Belarus)

    Objective: Comparison of the efficacy of STN neuromodulation after surgical intervention with Monitored Anesthesia Care (MAC) and using general anesthesia (GA). Background: The effectiveness of…
  • 2024 International Congress

    Imaging-based Troubleshooting Deep Brain Stimulation in Parkinson’s Disease

    J. Yamamoto, I. Paraguay, R. Barbosa, E. Barbosa, R. Cury (Sao Paulo, Brazil)

    Objective: Evaluate whether if electrodes reconstruction using Lead-DBS, an open source toolbox, in patients with Parkinson’s Disease (PwPDP) treated with Deep Brain Stimulation (DBS) presenting…
  • 2024 International Congress

    The Current State of Wearable Device Use in Parkinson’s Disease (A Survey of Individuals with Parkinson’s and Specialist Clinicians)

    S. Hirczy, Y. Lin, C. Zabetian (Seattle, USA)

    Objective: To develop a better understanding of the current use of consumer and medical wearable monitoring devices in the clinical management of PD and to…
  • 2024 International Congress

    The study of evaluating the impact of simulating indoor environments using virtual reality on gait in Parkinson’s Disease

    K. Seo, S. Emoto, K. Abe, T. Ishii, M. Miki, M. Hara, T. Yamamoto (Saitama, Japan)

    Objective: This study aims to quantitatively assess how indoor environments affect on gait disturbances in PD patients using virtual reality (VR). Background: Patients with Parkinson's…
  • 2024 International Congress

    Balancing Act: Smartphone Data and Machine Learning in Movement Disorder Classification

    S. Macneille, A. Kostic, A. Chu, J. Daneault (Newark, USA)

    Objective: Determine if machine learning models can classify healthy individuals and people with movement disorders using smartphone data collected during a simple balance task. Background:…
  • 2024 International Congress

    Identification of Fall Risk in Patients with Parkinson’s Disease Through Telemonitoring

    F. Kanellos, G. Rigas, A. Ntanis, N. Kostikis, S. Kontaxis, L. Liouta, C. Tsitsou, S. Konitsiotis (Ioannina, Greece)

    Objective: This work presents an analysis of real-world, device-reported outcomes from patients with Parkinson’s disease (PD) in Greece. A total of 82 patients were included…
  • 2024 International Congress

    Get Ready a mobile phone app a solution for patient engagement/remote management

    R. Mills, M. Gibbs, N. Pavese, D. Ledingham, A. Hussain, A. Jenkins, C. Nicholson (Newcastle, United Kingdom)

    Objective: The movement disorder DBS team at the Royal Victoria Infirmary, developed‘Get Ready®’ mobile phone app for patients who are candidates for DBS. The app…
  • 2024 International Congress

    Increased Risk of Suicidal Ideation in Patients with Spinocerebellar Ataxias

    C. Lin, L. Peppel, R. Lai, C. Rummey, P. Opal, J. Schmahmann, C. Gomez, H. Paulson, T. Zesiewicz, S. Perlman, G. Wilmot, S. Ying, C. Onyike, K. Bushara, M. Geschwind, K. Figueroa, S. Pulst, S. Subramony, A. Duquette, T. Ashizawa, A. Hamedani, M. Davis, S. Srinivasan, M. Burns, L. Moore, V. Shakkottai, L. Rosenthal, S. Kuo (Houston, USA)

    Objective: We aimed to investigate if individuals with spinocerebellar ataxias (SCAs) experience increased suicidal ideation and to identify associated factors. Background: Suicidality has been extensively…
  • 2024 International Congress

    Autosomal recessive spastic ataxia of Charlevoix–Saguenay: Case report with 3 family members affected.

    H. Pacheco Mendoza, L. Nuñez Orozco, P. Briseño López, A. Negrete Gómez, J. Delgado Uriarte (Mexico, Mexico)

    Objective: Report a case of ARSACS in a patient with 2 siblings also affected Background: Autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS) is a rare…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley